Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · IEX Real-Time Price · USD
0.735
+0.003 (0.42%)
At close: Jul 2, 2024, 4:00 PM
0.750
+0.015 (2.01%)
After-hours: Jul 2, 2024, 5:54 PM EDT
Bolt Biotherapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for BOLT stock have an average target of 1.25, with a low estimate of 1.00 and a high estimate of 1.50. The average target predicts an increase of 70.07% from the current stock price of 0.74.
Analyst Consensus: Hold
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for BOLT stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $3 → $1 | Buy → Hold | Downgrades | $3 → $1 | +36.05% | May 15, 2024 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 15, 2024 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $6 → $1.5 | Strong Buy → Hold | Downgrades | $6 → $1.5 | +104.08% | May 15, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 15, 2024 |
Financial Forecast
Revenue This Year
9.11M
from 7.88M
Increased by 15.66%
Revenue Next Year
4.15M
from 9.11M
Decreased by -54.43%
EPS This Year
-1.36
from -1.83
EPS Next Year
-1.09
from -1.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.8M | 13.1M | 13.8M | 36.8M | 52.5M |
| Avg | 9.1M | 4.2M | 6.4M | 11.9M | 25.5M |
| Low | 5.2M | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 62.6% | 44.1% | 231.9% | 470.2% | 341.2% |
| Avg | 15.7% | -54.4% | 55.3% | 84.6% | 114.3% |
| Low | -34.1% | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.01 | -0.78 | -0.69 | -0.58 | -0.41 |
| Avg | -1.36 | -1.09 | -1.06 | -0.56 | -0.40 |
| Low | -1.72 | -1.55 | -1.61 | -0.54 | -0.38 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.